- Home
- STOK vs NDMO Comparison
STOK vs NDMO Comparison
Compare STOK & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- NDMO
- Stock Information
- Founded
- STOK 2014
- NDMO 2019
- Country
- STOK United States
- NDMO United States
- Employees
- STOK N/A
- NDMO N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- STOK Health Care
- NDMO Finance
- Exchange
- STOK Nasdaq
- NDMO Nasdaq
- Market Cap
- STOK 556.7M
- NDMO 621.8M
- IPO Year
- STOK 2019
- NDMO N/A
- Fundamental
- Price
- STOK $8.33
- NDMO $10.50
- Analyst Decision
- STOK Strong Buy
- NDMO
- Analyst Count
- STOK 8
- NDMO 0
- Target Price
- STOK $23.83
- NDMO N/A
- AVG Volume (30 Days)
- STOK 830.1K
- NDMO 218.6K
- Earning Date
- STOK 03-24-2025
- NDMO 01-01-0001
- Dividend Yield
- STOK N/A
- NDMO 6.75%
- EPS Growth
- STOK N/A
- NDMO N/A
- EPS
- STOK N/A
- NDMO N/A
- Revenue
- STOK $16,742,999.00
- NDMO N/A
- Revenue This Year
- STOK $105.42
- NDMO N/A
- Revenue Next Year
- STOK $15.13
- NDMO N/A
- P/E Ratio
- STOK N/A
- NDMO N/A
- Revenue Growth
- STOK 81.08
- NDMO N/A
- 52 Week Low
- STOK $5.28
- NDMO $8.99
- 52 Week High
- STOK $17.58
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- STOK 32.00
- NDMO 55.65
- Support Level
- STOK $9.76
- NDMO $10.44
- Resistance Level
- STOK $11.11
- NDMO $10.54
- Average True Range (ATR)
- STOK 0.88
- NDMO 0.08
- MACD
- STOK -0.30
- NDMO -0.01
- Stochastic Oscillator
- STOK 2.31
- NDMO 44.20
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.